Drawing for HEMACORE

USPTO serial 79300391

HEMACORE

Reviewed by CopyMark Law Group

Reg. 6733679Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
SEVERSON, JUSTIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HEMACORE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marina Sigareva

Marina Sigareva Volpe Koenig30 South 17th StreetSuite 1800Philadelphia, PA 19103-4009

Goods and services

ClassDescriptionStatusFirst use
005Blood plasma, namely, for the diagnosis of hemostasis; albuminous preparations for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; biological preparations for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; diagnostic preparations for medical purposes; enzyme preparations for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; chemical reagents for medical or veterinary purposes, namely, for the diagnosis and treatment of hemostatic disorders; salts, namely, sodium salts, calcium salts, for medical purposes, namely, for the diagnosis and treatment of hemostatic disorders; enzymes for medical purposes, namely, for the diagnosis and treatment of hemostatic disordersACTIVE—
009Testing apparatus not for medical purposes, namely, for testing biological compounds; monitoring apparatus, other than for medical purposes, namely, for monitoring of spatiotemporal dynamics of biochemical reactions; apparatus and instruments for physics, namely, thermostats, pressure indicators, temperature indicators; chemistry apparatus and instruments, namely, scattering meters, spectrophotometers; measuring apparatus, namely, for measuring of spatiotemporal dynamics of biochemical reactions; computer programs, recorded for scientific, biological and medical purposes for performing tests and processing data; computer software, recorded, for scientific, biological and medical purposes for performing tests and processing dataACTIVE—
010Testing apparatus for medical purposes, namely, for the diagnosis of hemostasis; blood testing apparatus, namely, for the diagnosis of hemostasis; diagnostic apparatus for medical purposes, namely, for the diagnosis of hemostasis; medical apparatus and instruments, namely, for the diagnosis and treatment of hemostasis disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 17, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 7, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 7, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 13, 2022GPNXNOTIFICATION PROCESSED BY IB—
Mar 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 16, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 16, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 28, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 7, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 6, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 30, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 24, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 24, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 14, 2021RFNTREFUSAL PROCESSED BY IB—
Jan 26, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 25, 2021RFRRREFUSAL PROCESSED BY MPU—
Jan 5, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 4, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 2, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 29, 2020DOCKASSIGNED TO EXAMINER—
Dec 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance